U.S. markets close in 49 minutes
  • S&P 500

    +17.78 (+0.40%)
  • Dow 30

    +205.80 (+0.59%)
  • Nasdaq

    +94.28 (+0.64%)
  • Russell 2000

    +35.58 (+1.62%)
  • Crude Oil

    +0.94 (+1.38%)
  • Gold

    -8.80 (-0.48%)
  • Silver

    -0.28 (-1.08%)

    -0.0004 (-0.04%)
  • 10-Yr Bond

    +0.0360 (+3.04%)

    +0.0048 (+0.35%)

    +0.2800 (+0.26%)

    +1,585.50 (+4.00%)
  • CMC Crypto 200

    +36.66 (+3.76%)
  • FTSE 100

    -3.43 (-0.05%)
  • Nikkei 225

    +144.04 (+0.52%)

Trade Alert: The Chairman & CEO Of OPKO Health, Inc. (NASDAQ:OPK), Phillip Frost, Has Just Spent US$2.1m Buying A Few More Shares

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Those following along with OPKO Health, Inc. (NASDAQ:OPK) will no doubt be intrigued by the recent purchase of shares by Phillip Frost, Chairman & CEO of the company, who spent a stonking US$2.1m on stock at an average price of US$3.45. There's no denying a buy of that magnitude suggests conviction in a brighter future, although we do note that proportionally it only increased their holding by 0.3%.

See our latest analysis for OPKO Health

The Last 12 Months Of Insider Transactions At OPKO Health

In fact, the recent purchase by Phillip Frost was the biggest purchase of OPKO Health shares made by an insider individual in the last twelve months, according to our records. That implies that an insider found the current price of US$3.56 per share to be enticing. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. While we always like to see insider buying, it's less meaningful if the purchases were made at much lower prices, as the opportunity they saw may have passed. Happily, the OPKO Health insiders decided to buy shares at close to current prices.

While OPKO Health insiders bought shares during the last year, they didn't sell. They paid about US$1.69 on average. To my mind it is good that insiders have invested their own money in the company. However, we do note that they were buying at significantly lower prices than today's share price. The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!


There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).

Insider Ownership of OPKO Health

Many investors like to check how much of a company is owned by insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. It's great to see that OPKO Health insiders own 35% of the company, worth about US$844m. I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.

So What Does This Data Suggest About OPKO Health Insiders?

It is good to see recent purchasing. And an analysis of the transactions over the last year also gives us confidence. But on the other hand, the company made a loss during the last year, which makes us a little cautious. Along with the high insider ownership, this analysis suggests that insiders are quite bullish about OPKO Health. One for the watchlist, at least! So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. You'd be interested to know, that we found 2 warning signs for OPKO Health and we suggest you have a look.

Of course OPKO Health may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.